|
|
.
See Category: Diseases of the eye and adnexa
See Header: Primary iridocyclitis
ICD-10 (CM) Code and Descriptor
|
H20.019 |
Primary iridocyclitis, unspecified eye
In the inpatient setting, there should generally be very limited and rare
circumstances for which the laterality (right, left, bilateral) of a condition is unable to be
documented and reported.
|
H20019 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 7 |
ICD10
Position 10 |
| 82.81%
|
6.25%
|
3.13%
|
1.56%
|
3.13%
|
3.13%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H20.019*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
36
|
36
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
26
|
26
|
|
86140
|
C-REACTIVE PROTEIN |
20
|
20
|
|
86480
|
TB TEST CELL IMMUN MEASURE |
20
|
20
|
|
86592
|
SYPHILIS TEST NON-TREP QUAL |
20
|
20
|
|
85652
|
RBC SED RATE AUTOMATED |
17
|
17
|
|
86780
|
TREPONEMA PALLIDUM |
17
|
17
|
|
82164
|
ANGIOTENSIN I ENZYME TEST |
14
|
14
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
12
|
12
|
|
G0467
|
FQHC VISIT, ESTAB PT |
12
|
12
|
|
86812
|
HLA TYPING A B OR C |
10
|
10
|
|
86038
|
ANTINUCLEAR ANTIBODIES |
9
|
9
|
|
80053
|
COMPREHEN METABOLIC PANEL |
9
|
9
|
|
85549
|
MURAMIDASE |
8
|
8
|
|
86431
|
RHEUMATOID FACTOR QUANT |
7
|
7
|
|
86618
|
LYME DISEASE ANTIBODY |
7
|
7
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
6
|
6
|
|
86039
|
ANTINUCLEAR ANTIBODIES (ANA) |
5
|
5
|
|
86200
|
CCP ANTIBODY |
5
|
5
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
4
|
4
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H20.019 related to the following DRG Codes:
124-125
|
